# Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease

> **NCT00180544** · PHASE3 · TERMINATED · sponsor: **Abbott Medical Devices** · enrollment: 167 (actual)

## Conditions studied

- Renal Artery Obstruction

## Interventions

- **DEVICE:** Stenting: Renal Artery

## Key facts

- **NCT ID:** NCT00180544
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-07
- **Primary completion:** 2004-08
- **Final completion:** 2004-08
- **Target enrollment:** 167 (ACTUAL)
- **Why stopped:** Device superceded by next generation device. Enrollment stopped, long term follow up was completed in August of 2004.
- **Last updated:** 2008-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180544, "Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00180544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*